These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 28168990)

  • 1. Clinical assessment of cerebral hemodynamics in Moyamoya disease via multiple inversion time arterial spin labeling and dynamic susceptibility contrast-magnetic resonance imaging: A comparative study.
    Qiao PG; Han C; Zuo ZW; Wang YT; Pfeuffer J; Duan L; Qian T; Li GJ
    J Neuroradiol; 2017 Jul; 44(4):273-280. PubMed ID: 28168990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of MR mTI-ASL and DSC-PWI in evaluating cerebral hemodynamics of patients with Moyamoya disease.
    Zhang J; Xia C; Liu Y; Qian W; Peng W; Liu K; Li L; Zhao F; Li Z
    Medicine (Baltimore); 2018 Oct; 97(41):e12768. PubMed ID: 30313089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of delayed transit time on arterial spin labeling: correlation with dynamic susceptibility contrast perfusion magnetic resonance in moyamoya disease.
    Yun TJ; Sohn CH; Han MH; Kang HS; Kim JE; Yoon BW; Paeng JC; Choi SH; Kim JH; Song IC; Chang KH
    Invest Radiol; 2013 Nov; 48(11):795-802. PubMed ID: 23764569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-Dimensional Arterial Spin Labeling for the Evaluation of the Cerebral Hemodynamics in Ischemic and Hemorrhagic Moyamoya Disease.
    Bian H; Zhang L; Wang J
    Cerebrovasc Dis; 2024; 53(3):307-315. PubMed ID: 37722371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial spin-labeling cerebral perfusion changes after revascularization surgery in pediatric moyamoya disease and syndrome.
    Quon JL; Kim LH; Lober RM; Maleki M; Steinberg GK; Yeom KW
    J Neurosurg Pediatr; 2019 Apr; 23(4):486-492. PubMed ID: 30738390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial Spin Labeling MRI for Quantitative Assessment of Cerebral Perfusion Before and After Cerebral Revascularization in Children with Moyamoya Disease.
    Ha JY; Choi YH; Lee S; Cho YJ; Cheon JE; Kim IO; Kim WS
    Korean J Radiol; 2019 Jun; 20(6):985-996. PubMed ID: 31132824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of 3D pseudo-continuousarterial spin labeling perfusion imaging in moyamoya disease-Comparison with dynamic susceptibility contrast perfusion imaging.
    Zhang H; Lu M; Liu S; Liu D; Shen X; Sheng F; Han C; Cai J
    Front Neurosci; 2022; 16():944246. PubMed ID: 35992916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial coefficient of variation applied to arterial spin labeling MRI may contribute to predict surgical revascularization outcomes in pediatric moyamoya vasculopathy.
    Tortora D; Scavetta C; Rebella G; Bertamino M; Scala M; Giacomini T; Morana G; Pavanello M; Rossi A; Severino M
    Neuroradiology; 2020 Aug; 62(8):1003-1015. PubMed ID: 32415392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring Cerebral Perfusion Changes Using Arterial Spin-Labeling Perfusion MRI after Indirect Revascularization in Children with Moyamoya Disease.
    Lee SB; Lee S; Cho YJ; Choi YH; Cheon JE; Kim WS
    Korean J Radiol; 2021 Sep; 22(9):1537-1546. PubMed ID: 34132076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-contrast hemodynamic imaging of Moyamoya disease with MR fingerprinting ASL: A feasibility study.
    Su P; Liu P; Pinho MC; Thomas BP; Qiao Y; Huang J; Welch BG; Lu H
    Magn Reson Imaging; 2022 May; 88():116-122. PubMed ID: 35183659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in cerebral blood flow measurement using arterial spin labeling MRI between patients with moyamoya disease and patients with arteriosclerotic cerebrovascular disease.
    Ueda Y; Tanaka Y; Hara S; Inaji M; Ishii K; Maehara T; Nariai T
    Acta Radiol; 2023 Jan; 64(1):311-319. PubMed ID: 35037475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revascularization improves vascular hemodynamics - a study assessing cerebrovascular reserve and transit time in Moyamoya patients using MRI.
    Zhao MY; Armindo RD; Gauden AJ; Yim B; Tong E; Moseley M; Steinberg GK; Zaharchuk G
    J Cereb Blood Flow Metab; 2023 Nov; 43(2_suppl):138-151. PubMed ID: 36408536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of arterial spin labeling perfusion with dynamic susceptibility contrast perfusion in Moyamoya disease.
    Yadav N; Pendharkar H; Gupta AK; Prasad C; Shukla D; Kandavel T; Bansal S
    J Neurosci Rural Pract; 2023; 14(2):286-292. PubMed ID: 37181159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive Evaluation of CBF and Perfusion Delay of Moyamoya Disease Using Arterial Spin-Labeling MRI with Multiple Postlabeling Delays: Comparison with
    Hara S; Tanaka Y; Ueda Y; Hayashi S; Inaji M; Ishiwata K; Ishii K; Maehara T; Nariai T
    AJNR Am J Neuroradiol; 2017 Apr; 38(4):696-702. PubMed ID: 28209582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transit time corrected arterial spin labeling technique aids to overcome delayed transit time effect.
    Yun TJ; Sohn CH; Yoo RE; Kang KM; Choi SH; Kim JH; Park SW; Hwang M; Lebel RM
    Neuroradiology; 2018 Mar; 60(3):255-265. PubMed ID: 29288284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between Clinical Presentations and Hemodynamic Parameters Measured by Dynamic Susceptibility Contrast Magnetic Resonance Imaging in Adult Patients with Moyamoya Disease.
    Hirai S; Inaji M; Tanaka Y; Hara S; Nariai T; Maehara T
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2814-2820. PubMed ID: 28778721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and Long-Term MRI Assessed Hemodynamic Changes in Pediatric Moyamoya Patients After Revascularization.
    Zhao MY; Tong E; Duarte Armindo R; Fettahoglu A; Choi J; Bagley J; Yeom KW; Moseley M; Steinberg GK; Zaharchuk G
    J Magn Reson Imaging; 2024 Apr; 59(4):1349-1357. PubMed ID: 37515518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring Cerebral Perfusion Changes after Revascularization in Patients with Moyamoya Disease by Using Arterial Spin-labeling MR Imaging.
    Lee S; Yun TJ; Yoo RE; Yoon BW; Kang KM; Choi SH; Kim JH; Kim JE; Sohn CH; Han MH
    Radiology; 2018 Aug; 288(2):565-572. PubMed ID: 29714677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Delay Arterial Spin Labeling Provides More Accurate Cerebral Blood Flow Measurements in Moyamoya Patients: A Simultaneous Positron Emission Tomography/MRI Study.
    Fan AP; Guo J; Khalighi MM; Gulaka PK; Shen B; Park JH; Gandhi H; Holley D; Rutledge O; Singh P; Haywood T; Steinberg GK; Chin FT; Zaharchuk G
    Stroke; 2017 Sep; 48(9):2441-2449. PubMed ID: 28765286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.